Takuji Tanaka Selected Research

Takuji Tanaka Research Topics

Disease

136	Carcinogenesis 11/2023 - 01/2001
115	Neoplasms (Cancer) 05/2024 - 02/2002
59	Inflammation (Inflammations) 05/2024 - 11/2003
46	Body Weight (Weight, Body) 02/2017 - 02/2002
44	Adenocarcinoma 12/2023 - 03/2002
38	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2002
30	Colitis 12/2021 - 10/2003
26	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 09/2008
23	Obesity 08/2017 - 01/2008
18	Aberrant Crypt Foci 12/2014 - 02/2002
14	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2005
10	Carcinoma (Carcinomatosis) 01/2010 - 05/2002
9	Adenoma (Adenomas) 06/2017 - 09/2002
9	Insulin Resistance 01/2015 - 05/2009
7	Tongue Neoplasms (Tongue Neoplasm) 03/2007 - 05/2002
6	Fatty Liver 05/2024 - 01/2011
6	Fibrosis (Cirrhosis) 05/2024 - 09/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014 - 05/2002
4	Non-alcoholic Fatty Liver Disease 05/2024 - 01/2013
4	Ulcerative Colitis 01/2019 - 10/2003
4	Alcoholic Fatty Liver 09/2018 - 03/2016
4	Liver Neoplasms (Liver Cancer) 08/2017 - 05/2009
4	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2017 - 09/2002
4	Diabetes Mellitus 03/2016 - 10/2007
4	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 03/2002
4	Hyperlipidemias (Hyperlipidemia) 07/2014 - 10/2007
4	Infections 07/2013 - 01/2007
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2011 - 01/2002
3	Neoplasm Metastasis (Metastasis) 05/2023 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 05/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 03/2012
3	Lymphoma (Lymphomas) 11/2018 - 08/2007
3	Disease Progression 06/2017 - 03/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 03/2017 - 02/2010
3	Hyperinsulinism (Hyperinsulinemia) 03/2016 - 05/2009

Drug/Important Bio-Agent (IBA)

57	AzoxymethaneIBA 09/2023 - 02/2002
39	Drinking WaterIBA 01/2019 - 05/2002
32	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2002
32	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 10/2003
31	Dextrans (Dextran)FDA Link 01/2022 - 10/2003
19	beta CateninIBA 07/2010 - 09/2002
18	Dextran SulfateIBA 01/2021 - 02/2005
16	EnzymesIBA 11/2021 - 01/2001
15	AntioxidantsIBA 03/2016 - 01/2001
14	CarcinogensIBA 09/2023 - 01/2001
13	fucoxanthinIBA 12/2023 - 11/2004
13	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2018 - 02/2002
12	CytokinesIBA 05/2022 - 02/2005
12	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2017 - 01/2004
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2003
10	Messenger RNA (mRNA)IBA 06/2017 - 02/2006
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 10/2003
9	TeaIBA 04/2017 - 05/2008
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2023 - 04/2003
8	Carotenoids (Carotene)IBA 12/2021 - 11/2004
8	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 11/2003
8	FlavonoidsIBA 01/2012 - 01/2001
7	AdipokinesIBA 03/2016 - 05/2008
7	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2012 - 01/2003
7	auraptenIBA 02/2010 - 01/2004
7	PPAR gammaIBA 05/2007 - 04/2003
6	PhytochemicalsIBA 11/2023 - 01/2001
6	LigandsIBA 12/2021 - 04/2003
6	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2004
6	LipidsIBA 07/2017 - 06/2004
6	CateninsIBA 06/2017 - 06/2011
6	Branched-Chain Amino AcidsIBA 03/2017 - 05/2009
6	Insulin (Novolin)FDA Link 01/2015 - 05/2004
5	pitavastatin (itavastatin)FDA Link 07/2014 - 11/2007
5	SilymarinIBA 10/2011 - 01/2002
5	nobiletinIBA 01/2011 - 01/2004
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2007 - 06/2004
5	CyclinsIBA 02/2007 - 04/2003
5	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2006 - 02/2002
4	fucoxanthinolIBA 05/2021 - 07/2017
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 01/2013
4	(2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 06/2017 - 06/2004
4	astaxanthine (astaxanthin)IBA 03/2016 - 08/2011
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2014 - 05/2009
4	Insulin-Like PeptidesIBA 05/2014 - 09/2008
4	SesquiterpenesIBA 03/2013 - 10/2003
4	Interleukin-6 (Interleukin 6)IBA 03/2013 - 01/2011
4	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2013 - 01/2003
4	Prostaglandins EIBA 08/2011 - 05/2002
4	benzocycloheptapyridineIBA 01/2011 - 01/2005
4	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2011 - 01/2005
4	LeptinIBA 02/2010 - 05/2004
4	DNA (Deoxyribonucleic Acid)IBA 05/2007 - 01/2001
4	3-nitrotyrosineIBA 06/2006 - 09/2004
3	nitrosobis(2-oxopropyl)amine (NBOP)IBA 05/2021 - 06/2004
3	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 06/2017 - 01/2011
3	platelet-derived growth factor C (PDGF-C)IBA 03/2017 - 09/2012
3	AdiponectinIBA 03/2016 - 05/2008

Therapy/Procedure

45	Chemoprevention 01/2022 - 01/2001
18	Subcutaneous Injections 09/2017 - 02/2002
14	Intraperitoneal Injections 01/2016 - 03/2002
9	Therapeutics 05/2022 - 11/2005
4	Drug Therapy (Chemotherapy) 05/2023 - 03/2012
4	Oral Administration 01/2021 - 01/2009
3	Aftercare (After-Treatment) 11/2021 - 09/2002